Dr. med. Ramona Erber



Organisation


Pathologisches Institut


Publications (Download BibTeX)

Go to first page Go to previous page 1 of 2 Go to next page Go to last page

Fasching, P., Gaß, P., Häberle, L., Volz, B., Hein, A., Hack, C.,... Erber, R. (2019). Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer. Breast Cancer Research and Treatment. https://dx.doi.org/10.1007/s10549-019-05198-9
Häberle, L., Erber, R., Gaß, P., Hein, A., Jud, S., Langemann, H.,... Fasching, P. (2018). A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients. In ANNALS OF ONCOLOGY. Munich, DE: OXFORD: OXFORD UNIV PRESS.
Wunderle, M., Gaß, P., Häberle, L., Flesch, V.M., Rauh, C., Bani, M.,... Hein, A. (2018). BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients. Breast Cancer Research and Treatment, 171(1), 85-94. https://dx.doi.org/10.1007/s10549-018-4797-8
Gebrekidan, M., Erber, R., Hartmann, A., Fasching, P., Emons, J., Beckmann, M., & Bräuer, A. (2018). Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS). Technology in Cancer Research & Treatment, 17. https://dx.doi.org/10.1177/1533033818782532
Siegler, L., Erber, R., Burghaus, S., Brodkorb, T., Wachter, D., Wilkinson, N.,... Agaimy, A. (2018). Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening. Virchows Archiv. https://dx.doi.org/10.1007/s00428-018-2292-6
Erber, R., & Agaimy, A. (2018). Misses and near misses in diagnosing nodular fasciitis and morphologically related reactive myofibroblastic proliferations: experience of a referral center with emphasis on frequency of USP6 gene rearrangements. Virchows Archiv, 473(3), 351-360. https://dx.doi.org/10.1007/s00428-018-2350-0
Gaß, P., Lux, M.P., Rauh, C., Hein, A., Bani, M., Fiessler, C.,... Wunderle, M. (2018). Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer. BMC Cancer, 18(1). https://dx.doi.org/10.1186/s12885-018-4925-1
Wunderle, M., Olmes, G., Nabieva, N., Häberle, L., Jud, S., Hein, A.,... Fasching, P. (2018). Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data. Geburtshilfe und Frauenheilkunde, 78(5), 481-492. https://dx.doi.org/10.1055/a-0603-4350
Würfel, F., Erber, R., Hübner, H., Hein, A., Lux, M.P., Jud, S.,... Rübner, M. (2018). TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes. Breast Care, 13(1), 8-14.
Erber, R., Hartmann, A., Beckmann, M., Mackensen, A., Kremer, A., Reimann, H.,... Fasching, P. (2018). TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes. Pathologe, 39(Suppl 2), 236-240. https://dx.doi.org/10.1007/s00292-018-0526-7

Last updated on 2016-31-12 at 01:00